BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 14982793)

  • 41. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
    Larsen RA; Leal MA; Chan LS
    Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis.
    Wang H; Xu K; Liu L; Tan JP; Chen Y; Li Y; Fan W; Wei Z; Sheng J; Yang YY; Li L
    Biomaterials; 2010 Apr; 31(10):2874-81. PubMed ID: 20044131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluconazole-resistant cryptococcal meningitis.
    Momoff N; Parrish A
    S Afr Med J; 2003 Jun; 93(6):444. PubMed ID: 12916384
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of an Ommaya reservoir in the management of children with cryptococcal meningitis.
    Jiang PF; Yu HM; Zhou BL; Gao F; Shen SX; Xia ZZ; Shui QX
    Clin Neurol Neurosurg; 2010 Feb; 112(2):157-9. PubMed ID: 19910108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
    Allendoerfer R; Marquis AJ; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1991 Apr; 35(4):726-9. PubMed ID: 2069378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
    Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
    J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
    Córdoba S; Isla MG; Szusz W; Vivot W; Altamirano R; Davel G
    Mycoses; 2016 Jun; 59(6):351-6. PubMed ID: 26865081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.
    Witt MD; Lewis RJ; Larsen RA; Milefchik EN; Leal MA; Haubrich RH; Richie JA; Edwards JE; Ghannoum MA
    Clin Infect Dis; 1996 Feb; 22(2):322-8. PubMed ID: 8838190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
    Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
    Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
    Loyse A; Dromer F; Day J; Lortholary O; Harrison TS
    J Antimicrob Chemother; 2013 Nov; 68(11):2435-44. PubMed ID: 23788479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 53. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.
    Casadevall A; Spitzer ED; Webb D; Rinaldi MG
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1383-6. PubMed ID: 8328793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.
    Rossato L; Loreto ES; Venturini TP; de Azevedo MI; Al-Hatmi AMS; Santurio JM; Alves SH
    Mycoses; 2019 Jun; 62(6):508-512. PubMed ID: 30776159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapy for cryptococcal meningitis in patients with AIDS.
    Powderly WG
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S54-9. PubMed ID: 1562696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
    Ngan NTT; Thanh Hoang Le N; Vi Vi NN; Van NTT; Mai NTH; Van Anh D; Trieu PH; Lan NPH; Phu NH; Chau NVV; Lalloo DG; Hope W; Beardsley J; White NJ; Geskus R; Thwaites GE; Krysan D; Tai LTH; Kestelyn E; Binh TQ; Hung LQ; Tung NLN; Day JN
    Elife; 2021 Sep; 10():. PubMed ID: 34581270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.
    Smith KD; Achan B; Hullsiek KH; McDonald TR; Okagaki LH; Alhadab AA; Akampurira A; Rhein JR; Meya DB; Boulware DR; Nielsen K;
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7197-204. PubMed ID: 26324276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in managing HIV-associated cryptococcal meningitis.
    Boyer-Chammard T; Temfack E; Alanio A; Jarvis JN; Harrison TS; Lortholary O
    F1000Res; 2019; 8():. PubMed ID: 31275560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
    Dannaoui E; Abdul M; Arpin M; Michel-Nguyen A; Piens MA; Favel A; Lortholary O; Dromer F;
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2464-70. PubMed ID: 16801427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
    N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.